ISSN: 1879-6397

Journal Home

Journal Guideline

Journal of Huntington's disease Q1 Unclaimed

IOS Press BV Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Huntington's disease is a journal indexed in SJR in Neurology (clinical) and Cellular and Molecular Neuroscience with an H index of 35. It has an SJR impact factor of 1,038 and it has a best quartile of Q1. It has an SJR impact factor of 1,038.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Neurology (clinical) (Q1) Cellular and Molecular Neuroscience (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,038

SJR Impact factor

35

H Index

33

Total Docs (Last Year)

112

Total Docs (3 years)

1643

Total Refs

279

Total Cites (3 years)

107

Citable Docs (3 years)

2.15

Cites/Doc (2 years)

49.79

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Neurology Q1
Neuro-Oncology Q1
Nature Reviews Neurology Q1
JAMA Neurology Q1
Molecular Neurodegeneration Q1

Compare this journals

Aims and Scope

Best articles by citations

Computational Analysis of Transcriptional Regulation Sites at the HTT Gene Locus

Activity Behaviour of Minipigs Transgenic for the Huntington Gene

Huntingtin Interactions with Membrane Phospholipids: Strategic Targets for Therapeutic Intervention?

Analysis of Participant Withdrawal in Huntington Disease Clinical Trials

Huntingtin Supplies a csaA-Independent Function Essential for EDTA-Resistant Homotypic Cell Adhesion in Dictyostelium discoideum

Analysis of Participant Withdrawal in Huntington Disease Clinical Trials

Amyloid Precursor Protein Haploinsufficiency Preferentially Mediates Brain Iron Accumulation in Mice Transgenic for The Huntington's Disease Mutation

Huntington's Disease and Employment: The Relative Contributions of Cognitive and Motor Decline to the Decision to Leave Work

Huntington's Disease in Arab Countries

Huntington's Disease Outpatient Clinic for Functional Diagnosis and Treatment: Coming to Consensus: How Long Term Care Facility Procedures Complement Specialist Diagnosis and Treatment

Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype

Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes

SHOW MORE ARTICLES

Dual Task Performance May be a Better Measure of Cognitive Processing in Huntington's Disease than Traditional Attention Tests

Editorial on Clinical Trial's Corner

Functional Brain Correlates of Neuropsychiatric Symptoms in Presymptomatic Huntington's Disease: The IMAGE-HD Study

Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background

The Impact of Family History on the Clinical Features of Huntington's Disease

Circadian Rhythm, Cognition, and Mood Disorders in Huntington's Disease

Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington's Disease

Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease

Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease

Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease

Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease

Attitudes of Potential Participants Towards Molecular Therapy Trials in Huntington's Disease